These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 24195115)

  • 1. Progressive multifocal leukoencephalopathy in a patient taking the MS pill Gilenya.
    Clin Infect Dis; 2013 Oct; 57(8):ii. PubMed ID: 24195115
    [No Abstract]   [Full Text] [Related]  

  • 2. Oral fingolimod (gilenya) for multiple sclerosis.
    Med Lett Drugs Ther; 2010 Dec; 52(1353-1354):98-9. PubMed ID: 21344782
    [No Abstract]   [Full Text] [Related]  

  • 3. Fingolimod and multiple sclerosis: four cautionary tales.
    Bourdette D; Gilden D
    Neurology; 2012 Nov; 79(19):1942-3. PubMed ID: 23035058
    [No Abstract]   [Full Text] [Related]  

  • 4. Delayed fingolimod-associated asystole.
    Espinosa PS; Berger JR
    Mult Scler; 2011 Nov; 17(11):1387-9. PubMed ID: 21652609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gilenya safety update: cardiac and macula.
    Huggins A; Sergott RC
    Curr Opin Ophthalmol; 2012 Nov; 23(6):457-9. PubMed ID: 23047163
    [No Abstract]   [Full Text] [Related]  

  • 6. Fingolimod to treat severe multiple sclerosis after natalizumab-associated progressive multifocal leukoencephalopathy: a valid option?
    Maillart E; Louapre C; Lubetzki C; Papeix C
    Mult Scler; 2014 Apr; 20(4):505-9. PubMed ID: 24367037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fingolimod for multiple sclerosis.
    Drug Ther Bull; 2012 Feb; 50(2):18-20. PubMed ID: 22329953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trial watch: Phase III promise for oral multiple sclerosis therapy.
    Nat Rev Drug Discov; 2009 Feb; 8(2):98. PubMed ID: 19180099
    [No Abstract]   [Full Text] [Related]  

  • 9. Fingolimod: cardiovascular deaths.
    Prescrire Int; 2012 Apr; 21(126):99. PubMed ID: 22515137
    [No Abstract]   [Full Text] [Related]  

  • 10. Fingolimod for multiple sclerosis.
    Pelletier D; Hafler DA
    N Engl J Med; 2012 Jan; 366(4):339-47. PubMed ID: 22276823
    [No Abstract]   [Full Text] [Related]  

  • 11. Fingolimod-associated amenorrhea: a report of three cases.
    Alroughani R
    Mult Scler; 2014 Oct; 20(12):1662-4. PubMed ID: 24515730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Severe auto-immune hemolytic anemia in a fingolimod-treated multiple sclerosis patient.
    Lysandropoulos AP; Benghiat F
    Mult Scler; 2013 Oct; 19(11):1551-2. PubMed ID: 23817558
    [No Abstract]   [Full Text] [Related]  

  • 13. [New disease-modifying and symptomatic therapies for multiple sclerosis].
    Weise G; Buttmann M
    MMW Fortschr Med; 2012 Apr; 154(7):64-6. PubMed ID: 22558878
    [No Abstract]   [Full Text] [Related]  

  • 14. Comment on 'Fingolimod to treat severe MS after natalizumab-associated progressive multifocal leukoencephalopathy: a valid option?' Maillart et al.
    Tur C; Montalban X
    Mult Scler; 2014 Apr; 20(4):510-1. PubMed ID: 24468818
    [No Abstract]   [Full Text] [Related]  

  • 15. [New, effective immunomodulatory drug in treatment of multiple sclerosis: the fingolimod].
    Komoly S
    Ideggyogy Sz; 2012 Nov; 65(11-12):421-2. PubMed ID: 23289178
    [No Abstract]   [Full Text] [Related]  

  • 16. The pill times 2: what every woman with multiple sclerosis should know.
    Langer-Gould AM
    Neurology; 2014 Feb; 82(8):654-5. PubMed ID: 24463629
    [No Abstract]   [Full Text] [Related]  

  • 17. Melanoma occurring during treatment with fingolimod for multiple sclerosis: a case report.
    Conzett KB; Kolm I; Jelcic I; Kamarachev J; Dummer R; Braun R; French LE; Linnebank M; Hofbauer GF
    Arch Dermatol; 2011 Aug; 147(8):991-2. PubMed ID: 21844470
    [No Abstract]   [Full Text] [Related]  

  • 18. [A plan for risk management in the treatment of multiple sclerosis with gilenia (fingolimod)].
    Popova NF
    Zh Nevrol Psikhiatr Im S S Korsakova; 2011; 111(2 Pt 2):110-3. PubMed ID: 21916166
    [No Abstract]   [Full Text] [Related]  

  • 19. Branch retinal vein occlusion during fingolimod treatment in a patient with multiple sclerosis.
    Gallego-Pinazo R; España-Gregori E; Casanova B; Pardo-López D; Díaz-Llopis M
    J Neuroophthalmol; 2011 Sep; 31(3):292-3. PubMed ID: 21826025
    [No Abstract]   [Full Text] [Related]  

  • 20. Agency is under fire for refusing to supply details of sudden deaths after first dose of multiple sclerosis drug.
    Wise J
    BMJ; 2012 Feb; 344():e1360. PubMed ID: 22362460
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.